---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-106606"
form_type: "8-K"
ticker: "LAB"
cik: "0001162194"
company_name: "STANDARD BIOTOOLS INC."
filed_at: "2023-10-04T23:59:59+00:00"
generated_at: "2026-06-10T04:34:05.174937+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Standard BioTools and SomaLogic to merge in all-stock deal valued over $1B

## Summary
- SomaLogic shareholders get 1.11 LAB shares per SLGC share; combined ownership ~57% SLGC, ~43% LAB.
- Estimated $80M annual cost synergies by 2026; pro-forma 2023 revenue >$180M.
- Combined cash >$500M at close; LAB raises FY2023 revenue guidance to $100-105M.
- Michael Egholm to become CEO of combined company; Jeffrey Black as CFO.
- Standard BioTools and SomaLogic stockholders representing ~16% and ~1% voting power sign voting agreements.

## SEC filing metadata
- accession: 0001104659-23-106606
- form_type: 8-K
- ticker: LAB
- cik: 0001162194
- company_name: STANDARD BIOTOOLS INC.
- filed_at: 2023-10-04T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1162194/000110465923106606/0001104659-23-106606-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1162194/000110465923106606/tm2327474d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-106606
- JSON: https://secwatch.observer/filing/0001104659-23-106606.json
- Plain text: https://secwatch.observer/filing/0001104659-23-106606.txt

## Key facts
- Material Agreements
  STANDARD BIOTOOLS INC. entered into Agreement and Plan of Merger with SomaLogic, Inc. (effective 2023-10-04).
  - Action: entry
  - Agreement: merger
  - Counterparty: SomaLogic, Inc.
  - Effective: 2023-10-04
  source text: On October 4, 2023, Standard BioTools Inc., a Delaware corporation (“Standard BioTools” or the “Company”), SomaLogic, Inc., a Delaware corporation (“SomaLogic”), and Martis Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (“Merger Sub”), entered into an Agreement and Plan of Merger (the “Merger Agreement”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1162194/000110465923106606/0001104659-23-106606-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.